nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP1A2—Dacarbazine—muscle cancer	0.177	0.329	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—muscle cancer	0.101	0.187	CbGbCtD
Efavirenz—CYP1A2—Etoposide—muscle cancer	0.0865	0.161	CbGbCtD
Efavirenz—CYP3A4—Vincristine—muscle cancer	0.0494	0.0919	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—muscle cancer	0.0486	0.0903	CbGbCtD
Efavirenz—CYP3A4—Etoposide—muscle cancer	0.0453	0.0842	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—muscle cancer	0.0309	0.0574	CbGbCtD
Efavirenz—Renal impairment—Doxorubicin—muscle cancer	0.000862	0.00187	CcSEcCtD
Efavirenz—Paraesthesia—Vincristine—muscle cancer	0.000861	0.00186	CcSEcCtD
Efavirenz—Malaise—Etoposide—muscle cancer	0.000859	0.00186	CcSEcCtD
Efavirenz—Dermatitis bullous—Doxorubicin—muscle cancer	0.000858	0.00186	CcSEcCtD
Efavirenz—Breast disorder—Methotrexate—muscle cancer	0.000856	0.00185	CcSEcCtD
Efavirenz—Vertigo—Etoposide—muscle cancer	0.000856	0.00185	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000853	0.00185	CcSEcCtD
Efavirenz—Body temperature increased—Dactinomycin—muscle cancer	0.000849	0.00184	CcSEcCtD
Efavirenz—Abdominal pain—Dactinomycin—muscle cancer	0.000849	0.00184	CcSEcCtD
Efavirenz—Loss of consciousness—Etoposide—muscle cancer	0.000837	0.00181	CcSEcCtD
Efavirenz—Decreased appetite—Vincristine—muscle cancer	0.000834	0.00181	CcSEcCtD
Efavirenz—Cough—Etoposide—muscle cancer	0.000831	0.0018	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Vincristine—muscle cancer	0.000828	0.00179	CcSEcCtD
Efavirenz—Fatigue—Vincristine—muscle cancer	0.000827	0.00179	CcSEcCtD
Efavirenz—Convulsion—Etoposide—muscle cancer	0.000825	0.00179	CcSEcCtD
Efavirenz—Hypertension—Etoposide—muscle cancer	0.000822	0.00178	CcSEcCtD
Efavirenz—Pain—Vincristine—muscle cancer	0.00082	0.00178	CcSEcCtD
Efavirenz—Constipation—Vincristine—muscle cancer	0.00082	0.00178	CcSEcCtD
Efavirenz—Diplopia—Doxorubicin—muscle cancer	0.00082	0.00178	CcSEcCtD
Efavirenz—Asthma—Methotrexate—muscle cancer	0.000819	0.00177	CcSEcCtD
Efavirenz—Chest pain—Etoposide—muscle cancer	0.000811	0.00175	CcSEcCtD
Efavirenz—Migraine—Doxorubicin—muscle cancer	0.000807	0.00175	CcSEcCtD
Efavirenz—Affect lability—Doxorubicin—muscle cancer	0.000807	0.00175	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000805	0.00174	CcSEcCtD
Efavirenz—Pancreatitis—Methotrexate—muscle cancer	0.000803	0.00174	CcSEcCtD
Efavirenz—Discomfort—Etoposide—muscle cancer	0.000801	0.00173	CcSEcCtD
Efavirenz—Hypersensitivity—Dactinomycin—muscle cancer	0.000791	0.00171	CcSEcCtD
Efavirenz—Gastrointestinal pain—Vincristine—muscle cancer	0.000784	0.0017	CcSEcCtD
Efavirenz—Confusional state—Etoposide—muscle cancer	0.000784	0.0017	CcSEcCtD
Efavirenz—Pancytopenia—Methotrexate—muscle cancer	0.000777	0.00168	CcSEcCtD
Efavirenz—Mood swings—Doxorubicin—muscle cancer	0.000777	0.00168	CcSEcCtD
Efavirenz—Ataxia—Doxorubicin—muscle cancer	0.000771	0.00167	CcSEcCtD
Efavirenz—Asthenia—Dactinomycin—muscle cancer	0.00077	0.00167	CcSEcCtD
Efavirenz—Blood creatinine increased—Doxorubicin—muscle cancer	0.000768	0.00166	CcSEcCtD
Efavirenz—Thrombocytopenia—Etoposide—muscle cancer	0.000761	0.00165	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000761	0.00165	CcSEcCtD
Efavirenz—Tachycardia—Etoposide—muscle cancer	0.000758	0.00164	CcSEcCtD
Efavirenz—Body temperature increased—Vincristine—muscle cancer	0.000758	0.00164	CcSEcCtD
Efavirenz—Abdominal pain—Vincristine—muscle cancer	0.000758	0.00164	CcSEcCtD
Efavirenz—Skin disorder—Etoposide—muscle cancer	0.000755	0.00163	CcSEcCtD
Efavirenz—Hyperhidrosis—Etoposide—muscle cancer	0.000751	0.00163	CcSEcCtD
Efavirenz—Photosensitivity reaction—Methotrexate—muscle cancer	0.000747	0.00162	CcSEcCtD
Efavirenz—Hypokalaemia—Doxorubicin—muscle cancer	0.000746	0.00162	CcSEcCtD
Efavirenz—Breast disorder—Doxorubicin—muscle cancer	0.000741	0.0016	CcSEcCtD
Efavirenz—Anorexia—Etoposide—muscle cancer	0.000741	0.0016	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000739	0.0016	CcSEcCtD
Efavirenz—Diarrhoea—Dactinomycin—muscle cancer	0.000735	0.00159	CcSEcCtD
Efavirenz—Pneumonia—Methotrexate—muscle cancer	0.000734	0.00159	CcSEcCtD
Efavirenz—Nasopharyngitis—Doxorubicin—muscle cancer	0.000733	0.00159	CcSEcCtD
Efavirenz—Infestation NOS—Methotrexate—muscle cancer	0.00073	0.00158	CcSEcCtD
Efavirenz—Infestation—Methotrexate—muscle cancer	0.00073	0.00158	CcSEcCtD
Efavirenz—Drowsiness—Methotrexate—muscle cancer	0.00073	0.00158	CcSEcCtD
Efavirenz—Depression—Methotrexate—muscle cancer	0.000728	0.00158	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000724	0.00157	CcSEcCtD
Efavirenz—Muscular weakness—Doxorubicin—muscle cancer	0.000723	0.00157	CcSEcCtD
Efavirenz—Renal failure—Methotrexate—muscle cancer	0.000717	0.00155	CcSEcCtD
Efavirenz—Abdominal distension—Doxorubicin—muscle cancer	0.000714	0.00154	CcSEcCtD
Efavirenz—Asthma—Doxorubicin—muscle cancer	0.000709	0.00153	CcSEcCtD
Efavirenz—Hypersensitivity—Vincristine—muscle cancer	0.000707	0.00153	CcSEcCtD
Efavirenz—Sweating—Methotrexate—muscle cancer	0.0007	0.00151	CcSEcCtD
Efavirenz—Paraesthesia—Etoposide—muscle cancer	0.000698	0.00151	CcSEcCtD
Efavirenz—Haematuria—Methotrexate—muscle cancer	0.000696	0.00151	CcSEcCtD
Efavirenz—Pancreatitis—Doxorubicin—muscle cancer	0.000695	0.0015	CcSEcCtD
Efavirenz—Dyspnoea—Etoposide—muscle cancer	0.000693	0.0015	CcSEcCtD
Efavirenz—Somnolence—Etoposide—muscle cancer	0.000691	0.0015	CcSEcCtD
Efavirenz—Hepatobiliary disease—Methotrexate—muscle cancer	0.00069	0.00149	CcSEcCtD
Efavirenz—Asthenia—Vincristine—muscle cancer	0.000688	0.00149	CcSEcCtD
Efavirenz—Vomiting—Dactinomycin—muscle cancer	0.000683	0.00148	CcSEcCtD
Efavirenz—Rash—Dactinomycin—muscle cancer	0.000677	0.00147	CcSEcCtD
Efavirenz—Decreased appetite—Etoposide—muscle cancer	0.000676	0.00146	CcSEcCtD
Efavirenz—Pancytopenia—Doxorubicin—muscle cancer	0.000673	0.00146	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Etoposide—muscle cancer	0.000671	0.00145	CcSEcCtD
Efavirenz—Fatigue—Etoposide—muscle cancer	0.00067	0.00145	CcSEcCtD
Efavirenz—Pain—Etoposide—muscle cancer	0.000665	0.00144	CcSEcCtD
Efavirenz—Constipation—Etoposide—muscle cancer	0.000665	0.00144	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000659	0.00143	CcSEcCtD
Efavirenz—Diarrhoea—Vincristine—muscle cancer	0.000656	0.00142	CcSEcCtD
Efavirenz—Hepatitis—Methotrexate—muscle cancer	0.000655	0.00142	CcSEcCtD
Efavirenz—Urinary tract disorder—Methotrexate—muscle cancer	0.000647	0.0014	CcSEcCtD
Efavirenz—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000647	0.0014	CcSEcCtD
Efavirenz—Urethral disorder—Methotrexate—muscle cancer	0.000642	0.00139	CcSEcCtD
Efavirenz—Feeling abnormal—Etoposide—muscle cancer	0.00064	0.00139	CcSEcCtD
Efavirenz—Hyperglycaemia—Doxorubicin—muscle cancer	0.000639	0.00138	CcSEcCtD
Efavirenz—Nausea—Dactinomycin—muscle cancer	0.000638	0.00138	CcSEcCtD
Efavirenz—Pneumonia—Doxorubicin—muscle cancer	0.000636	0.00138	CcSEcCtD
Efavirenz—Gastrointestinal pain—Etoposide—muscle cancer	0.000635	0.00138	CcSEcCtD
Efavirenz—Dizziness—Vincristine—muscle cancer	0.000634	0.00137	CcSEcCtD
Efavirenz—Infestation NOS—Doxorubicin—muscle cancer	0.000632	0.00137	CcSEcCtD
Efavirenz—Infestation—Doxorubicin—muscle cancer	0.000632	0.00137	CcSEcCtD
Efavirenz—Drowsiness—Doxorubicin—muscle cancer	0.000632	0.00137	CcSEcCtD
Efavirenz—Visual impairment—Methotrexate—muscle cancer	0.000631	0.00137	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000627	0.00136	CcSEcCtD
Efavirenz—Renal failure—Doxorubicin—muscle cancer	0.000621	0.00134	CcSEcCtD
Efavirenz—Erythema multiforme—Methotrexate—muscle cancer	0.00062	0.00134	CcSEcCtD
Efavirenz—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00062	0.00134	CcSEcCtD
Efavirenz—Urticaria—Etoposide—muscle cancer	0.000617	0.00134	CcSEcCtD
Efavirenz—Jaundice—Doxorubicin—muscle cancer	0.000616	0.00133	CcSEcCtD
Efavirenz—Abdominal pain—Etoposide—muscle cancer	0.000614	0.00133	CcSEcCtD
Efavirenz—Body temperature increased—Etoposide—muscle cancer	0.000614	0.00133	CcSEcCtD
Efavirenz—Eye disorder—Methotrexate—muscle cancer	0.000612	0.00133	CcSEcCtD
Efavirenz—Tinnitus—Methotrexate—muscle cancer	0.000611	0.00132	CcSEcCtD
Efavirenz—Vomiting—Vincristine—muscle cancer	0.00061	0.00132	CcSEcCtD
Efavirenz—Cardiac disorder—Methotrexate—muscle cancer	0.000608	0.00132	CcSEcCtD
Efavirenz—Sweating—Doxorubicin—muscle cancer	0.000606	0.00131	CcSEcCtD
Efavirenz—Rash—Vincristine—muscle cancer	0.000605	0.00131	CcSEcCtD
Efavirenz—Dermatitis—Vincristine—muscle cancer	0.000604	0.00131	CcSEcCtD
Efavirenz—Haematuria—Doxorubicin—muscle cancer	0.000603	0.0013	CcSEcCtD
Efavirenz—Headache—Vincristine—muscle cancer	0.000601	0.0013	CcSEcCtD
Efavirenz—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000598	0.00129	CcSEcCtD
Efavirenz—Angiopathy—Methotrexate—muscle cancer	0.000594	0.00129	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—muscle cancer	0.000593	0.00128	CcSEcCtD
Efavirenz—Immune system disorder—Methotrexate—muscle cancer	0.000592	0.00128	CcSEcCtD
Efavirenz—Mediastinal disorder—Methotrexate—muscle cancer	0.000591	0.00128	CcSEcCtD
Efavirenz—Alopecia—Methotrexate—muscle cancer	0.000579	0.00125	CcSEcCtD
Efavirenz—Hypersensitivity—Etoposide—muscle cancer	0.000573	0.00124	CcSEcCtD
Efavirenz—Malnutrition—Methotrexate—muscle cancer	0.00057	0.00123	CcSEcCtD
Efavirenz—Erythema—Methotrexate—muscle cancer	0.00057	0.00123	CcSEcCtD
Efavirenz—Nausea—Vincristine—muscle cancer	0.00057	0.00123	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—muscle cancer	0.000569	0.00123	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—muscle cancer	0.000567	0.00123	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—muscle cancer	0.000565	0.00122	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—muscle cancer	0.00056	0.00121	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—muscle cancer	0.000559	0.00121	CcSEcCtD
Efavirenz—Dysgeusia—Methotrexate—muscle cancer	0.000559	0.00121	CcSEcCtD
Efavirenz—Asthenia—Etoposide—muscle cancer	0.000558	0.00121	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—muscle cancer	0.000558	0.00121	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—muscle cancer	0.000556	0.0012	CcSEcCtD
Efavirenz—Back pain—Methotrexate—muscle cancer	0.000552	0.00119	CcSEcCtD
Efavirenz—Pruritus—Etoposide—muscle cancer	0.00055	0.00119	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—muscle cancer	0.000547	0.00118	CcSEcCtD
Efavirenz—Vision blurred—Methotrexate—muscle cancer	0.000538	0.00116	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—muscle cancer	0.000536	0.00116	CcSEcCtD
Efavirenz—Diarrhoea—Etoposide—muscle cancer	0.000532	0.00115	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—muscle cancer	0.00053	0.00115	CcSEcCtD
Efavirenz—Ill-defined disorder—Methotrexate—muscle cancer	0.000529	0.00115	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—muscle cancer	0.000529	0.00114	CcSEcCtD
Efavirenz—Anaemia—Methotrexate—muscle cancer	0.000527	0.00114	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—muscle cancer	0.000527	0.00114	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—muscle cancer	0.000527	0.00114	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—muscle cancer	0.000515	0.00111	CcSEcCtD
Efavirenz—Malaise—Methotrexate—muscle cancer	0.000514	0.00111	CcSEcCtD
Efavirenz—Dizziness—Etoposide—muscle cancer	0.000514	0.00111	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—muscle cancer	0.000512	0.00111	CcSEcCtD
Efavirenz—Vertigo—Methotrexate—muscle cancer	0.000512	0.00111	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—muscle cancer	0.000511	0.00111	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—muscle cancer	0.000507	0.0011	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—muscle cancer	0.000501	0.00109	CcSEcCtD
Efavirenz—Cough—Methotrexate—muscle cancer	0.000498	0.00108	CcSEcCtD
Efavirenz—Convulsion—Methotrexate—muscle cancer	0.000494	0.00107	CcSEcCtD
Efavirenz—Vomiting—Etoposide—muscle cancer	0.000494	0.00107	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—muscle cancer	0.000494	0.00107	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—muscle cancer	0.000494	0.00107	CcSEcCtD
Efavirenz—Rash—Etoposide—muscle cancer	0.00049	0.00106	CcSEcCtD
Efavirenz—Dermatitis—Etoposide—muscle cancer	0.00049	0.00106	CcSEcCtD
Efavirenz—Headache—Etoposide—muscle cancer	0.000487	0.00105	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—muscle cancer	0.000487	0.00105	CcSEcCtD
Efavirenz—Arthralgia—Methotrexate—muscle cancer	0.000486	0.00105	CcSEcCtD
Efavirenz—Myalgia—Methotrexate—muscle cancer	0.000486	0.00105	CcSEcCtD
Efavirenz—Chest pain—Methotrexate—muscle cancer	0.000486	0.00105	CcSEcCtD
Efavirenz—Tension—Doxorubicin—muscle cancer	0.000485	0.00105	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—muscle cancer	0.000484	0.00105	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000482	0.00104	CcSEcCtD
Efavirenz—Discomfort—Methotrexate—muscle cancer	0.00048	0.00104	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—muscle cancer	0.00048	0.00104	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—muscle cancer	0.000478	0.00103	CcSEcCtD
Efavirenz—Confusional state—Methotrexate—muscle cancer	0.000469	0.00102	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—muscle cancer	0.000465	0.00101	CcSEcCtD
Efavirenz—Nausea—Etoposide—muscle cancer	0.000462	0.000999	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—muscle cancer	0.000458	0.000992	CcSEcCtD
Efavirenz—Nervous system disorder—Methotrexate—muscle cancer	0.000457	0.000988	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—muscle cancer	0.000456	0.000988	CcSEcCtD
Efavirenz—Thrombocytopenia—Methotrexate—muscle cancer	0.000456	0.000986	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—muscle cancer	0.000454	0.000982	CcSEcCtD
Efavirenz—Skin disorder—Methotrexate—muscle cancer	0.000452	0.000979	CcSEcCtD
Efavirenz—Hyperhidrosis—Methotrexate—muscle cancer	0.00045	0.000974	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—muscle cancer	0.000445	0.000964	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—muscle cancer	0.000444	0.00096	CcSEcCtD
Efavirenz—Anorexia—Methotrexate—muscle cancer	0.000444	0.00096	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—muscle cancer	0.000443	0.000959	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—muscle cancer	0.000436	0.000945	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—muscle cancer	0.000434	0.00094	CcSEcCtD
Efavirenz—Cough—Doxorubicin—muscle cancer	0.000431	0.000933	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—muscle cancer	0.000428	0.000926	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—muscle cancer	0.000426	0.000923	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000424	0.000918	CcSEcCtD
Efavirenz—Insomnia—Methotrexate—muscle cancer	0.000421	0.000911	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—muscle cancer	0.00042	0.00091	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—muscle cancer	0.00042	0.00091	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—muscle cancer	0.00042	0.00091	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—muscle cancer	0.000419	0.000907	CcSEcCtD
Efavirenz—Paraesthesia—Methotrexate—muscle cancer	0.000418	0.000905	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000418	0.000904	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—muscle cancer	0.000415	0.000899	CcSEcCtD
Efavirenz—Dyspnoea—Methotrexate—muscle cancer	0.000415	0.000898	CcSEcCtD
Efavirenz—Somnolence—Methotrexate—muscle cancer	0.000414	0.000896	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—muscle cancer	0.000411	0.00089	CcSEcCtD
Efavirenz—Dyspepsia—Methotrexate—muscle cancer	0.00041	0.000887	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—muscle cancer	0.000406	0.00088	CcSEcCtD
Efavirenz—Decreased appetite—Methotrexate—muscle cancer	0.000405	0.000876	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000402	0.00087	CcSEcCtD
Efavirenz—Fatigue—Methotrexate—muscle cancer	0.000401	0.000869	CcSEcCtD
Efavirenz—Pain—Methotrexate—muscle cancer	0.000398	0.000862	CcSEcCtD
Efavirenz—Shock—Doxorubicin—muscle cancer	0.000397	0.000858	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—muscle cancer	0.000395	0.000856	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—muscle cancer	0.000395	0.000854	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—muscle cancer	0.000393	0.000851	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—muscle cancer	0.000392	0.000847	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—muscle cancer	0.00039	0.000843	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—muscle cancer	0.000384	0.000832	CcSEcCtD
Efavirenz—Feeling abnormal—Methotrexate—muscle cancer	0.000384	0.00083	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methotrexate—muscle cancer	0.000381	0.000824	CcSEcCtD
Efavirenz—Urticaria—Methotrexate—muscle cancer	0.00037	0.0008	CcSEcCtD
Efavirenz—Body temperature increased—Methotrexate—muscle cancer	0.000368	0.000796	CcSEcCtD
Efavirenz—Abdominal pain—Methotrexate—muscle cancer	0.000368	0.000796	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000367	0.000795	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—muscle cancer	0.000365	0.000789	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—muscle cancer	0.000362	0.000783	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—muscle cancer	0.000359	0.000778	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—muscle cancer	0.000358	0.000776	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—muscle cancer	0.000355	0.000768	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—muscle cancer	0.00035	0.000758	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000348	0.000753	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—muscle cancer	0.000348	0.000752	CcSEcCtD
Efavirenz—Pain—Doxorubicin—muscle cancer	0.000345	0.000746	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—muscle cancer	0.000345	0.000746	CcSEcCtD
Efavirenz—Hypersensitivity—Methotrexate—muscle cancer	0.000343	0.000742	CcSEcCtD
Efavirenz—Asthenia—Methotrexate—muscle cancer	0.000334	0.000723	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—muscle cancer	0.000332	0.000719	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00033	0.000713	CcSEcCtD
Efavirenz—Pruritus—Methotrexate—muscle cancer	0.000329	0.000713	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—muscle cancer	0.00032	0.000693	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—muscle cancer	0.000319	0.00069	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—muscle cancer	0.000319	0.00069	CcSEcCtD
Efavirenz—Diarrhoea—Methotrexate—muscle cancer	0.000318	0.000689	CcSEcCtD
Efavirenz—Dizziness—Methotrexate—muscle cancer	0.000308	0.000666	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—muscle cancer	0.000297	0.000643	CcSEcCtD
Efavirenz—Vomiting—Methotrexate—muscle cancer	0.000296	0.000641	CcSEcCtD
Efavirenz—Rash—Methotrexate—muscle cancer	0.000294	0.000635	CcSEcCtD
Efavirenz—Dermatitis—Methotrexate—muscle cancer	0.000293	0.000635	CcSEcCtD
Efavirenz—Headache—Methotrexate—muscle cancer	0.000292	0.000631	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—muscle cancer	0.000289	0.000626	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—muscle cancer	0.000285	0.000617	CcSEcCtD
Efavirenz—Nausea—Methotrexate—muscle cancer	0.000277	0.000598	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—muscle cancer	0.000276	0.000597	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—muscle cancer	0.000267	0.000577	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—muscle cancer	0.000256	0.000555	CcSEcCtD
Efavirenz—Rash—Doxorubicin—muscle cancer	0.000254	0.00055	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—muscle cancer	0.000254	0.00055	CcSEcCtD
Efavirenz—Headache—Doxorubicin—muscle cancer	0.000253	0.000547	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—muscle cancer	0.000239	0.000518	CcSEcCtD
